Drug-drug interactions between Highly Active Antiretroviral Therapy and Antiblastic chemotherapy in cancer patients with HIV infection

Drug-drug interactions between Highly Active Antiretroviral Therapy and Antiblastic chemotherapy in cancer patients with HIV infection

The introduction of Highly Active Antiretroviral Therapy (HAART) into clinical practice has 27 dramatically changed the natural approach of HIV-related cancers. Several studies have shown that 28 intensive antiblastic chemotherapy (AC) is feasible in HIV-infected patients with cancer, and that the 2...

Full description

Bibliographic Details
Main Authors: Massimiliano eBerretta, Michele eCaraglia, Ferdinando eMartellotta, Silvia eZappavigna, Angela eLombardi, Carla eFierro, Luigi eAtripaldi, Tommaso eMuto, Daniela eValente, Paolo eDe Paoli, Umberto eTirelli, Raffaele eDi Francia
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-03-01
Series:Frontiers in Pharmacology
Subjects:
HIV
Cancer
pharmacogenomics
aids
antiretroviral therapy
polymorphisms Cytochrome P450
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00071/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00071/full

Similar Items